Logo
  • About
  • Contact
  • (888) 441-8033

Stonegate Capital Partners Updates Coverage on Cingulate Inc. (NASDAQ: CING) 2Q25

DALLAS, TX -- August 21st, 2025 -- Cingulate Inc. (NASDAQ: CING): Stonegate Capital Partners updates their coverage on Cingulate Inc. (NASDAQ: CING). Cingulate reported 2Q25 results that highlight continued progress toward the commercial launch of its lead ADHD asset, CTx-1301...

View full release

Sethera Therapeutics Unveils Breakthrough Enzymatic Platform for Next-Generation Peptide Drugs

SALT LAKE CITY, Utah August 21, 2025 — Sethera Therapeutics today announced publication in the Proceedings of the National Academy of Sciences (PNAS) of peer-reviewed results describing an enzymatic crosslinking platform that forges durable thioether “staples,” locking peptide...

View full release

Adelaide Perez Brings Ocean Beauty to the Canvas

Who is Adelaide Janet Perez? At just 17, Adelaide Janet Perez is already making waves (pun absolutely intended) with her paintings — vivid, emotional works that blend realism with a deep love for nature. Her art doesn’t just show you the sea’s beauty; it makes you feel it, and...

View full release

Stonegate Capital Partners Initiates Coverage on American Tungsten Corp. (CSE: TUNG)

DALLAS, TX -- August 20th, 2025 -- American Tungsten Corp. (CSE: TUNG): Stonegate Capital Partners initiates their coverage on American Tungsten Corp. (CSE: TUNG). In 1Q25, American Tungsten Corp. reported a net loss of C$1.87M (vs. C$63.7K in 1Q24), reflecting increased inves...

View full release

Stonegate Updates Coverage on Incannex Healthcare Inc. (NasdaqGM:IXHL) 3Q 2025 - Update

DALLAS, TX -- August 19th, 2025 -- Incannex Healthcare Inc. (NasdaqGM:IXHL): Stonegate Capital Partners updates their coverage on Incannex Healthcare Inc. (NasdaqGM:IXHL). Recently, IXHL has made significant progress on its IHL-42X asset after very positive topline results fro...

View full release

BioMed X and Novo Nordisk Launch New Collaboration in Oral Peptide Drug Delivery

Heidelberg, Germany, August 19, 2025 – BioMed X, an independent biomedical research institute based in Heidelberg, Germany, announced today the launch of a new collaboration with Novo Nordisk, a leading global healthcare company headquartered in Denmark. This partnership aims ...

View full release

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (NASDAQ: ACOG) Q2 2025

DALLAS, TX -- August 15th, 2025 -- Alpha Cognition Inc. (NASDAQ: ACOG): Stonegate Capital Partners updates their coverage on Alpha Cognition Inc. (NASDAQ: ACOG). Alpha Cognition advanced its first full quarter of ZUNVEYL® commercialization in 2Q25, driving meaningful early ado...

View full release

Sarson Funds Names Whitney Kalmbach Chief Operations Officer

INDIANAPOLIS — Aug. 15, 2025 — Sarson Funds, a digital asset investment firm focused on early stage crypto projects and Decentralized AI, today announced the appointment of Whitney Kalmbach as Chief Operations Officer. In this role, she will oversee the firm’s operational stra...

View full release

Stonegate Capital Partners Updates Coverage On Aemetis, Inc. (Nasdaq: AMTX) Q2 2025

DALLAS, TX -- August 14th, 2025 --  Stonegate Capital Partners updates coverage on Aemetis, Inc. (Nasdaq:AMTX). Aemetis’ results reinforced that the Company’s Dairy RNG platform is entering a high-growth phase, supported by regulatory approvals, capacity expansion, and favorab...

View full release

Stonegate Updates Coverage on Burcon Nutrascience Corporation (TSX: BU) FY26 Q1

DALLAS, TX -- August 14th, 2025 --Burcon Nutrascience Corporation (TSX: BU): Stonegate Capital Partners updates their coverage on Burcon Nutrascience Corporation (TSX: BU). During 1Q26, Burcon advanced meaningfully in its commercialization strategy. Within 90 days of commissio...

View full release
  • « First
  • ‹ Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • Next ›
  • Last »
©2025 Reportable, Inc.
Terms and Conditions | Privacy Policy